Cutler Group’s NovoCure NVCR Stock Holding History

Cutler Group’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,900	Closed	-$2K	–	4163
2023 Q2	$2K	Sell	5,900 -9,100	-61%	-$565K	﹤0.01%	3069
2023 Q1	$18K	Buy	15,000 +9,000	+150%	+$719K	﹤0.01%	1982
2022 Q4	$100K	Buy	6,000 +1,100	+22%	+$82.8K	0.01%	1153
2022 Q3	$63K	Buy	4,900 +1,000	+26%	+$78K	﹤0.01%	1741
2022 Q2	$43K	Sell	3,900 -9,100	-70%	-$685K	﹤0.01%	2045
2022 Q1	$96K	Buy	+13,000	New	+$958K	0.01%	1740
2021 Q1	–	Sell	-900	Closed	-$84K	–	6076
2020 Q4	$84K	Hold	900	–	–	﹤0.01%	1652
2020 Q3	$29K	Hold	900	–	–	﹤0.01%	2185
2020 Q2	$2K	Hold	900	–	–	﹤0.01%	3799
2020 Q1	$9K	Buy	+900	New	+$71.1K	﹤0.01%	2774
2019 Q4	–	Sell	-6,000	Closed	-$62K	–	4407
2019 Q3	$62K	Hold	6,000	–	–	0.01%	1385
2019 Q2	$37K	Buy	+6,000	New	+$304K	﹤0.01%	1773
2018 Q1	–	Sell	-9,800	Closed	-$5K	–	4988
2017 Q4	$5K	Sell	9,800 -2,900	-23%	-$55.8K	﹤0.01%	3643
2017 Q3	$27K	Sell	12,700 -58,900	-82%	-$1.16M	﹤0.01%	2848
2017 Q2	$269K	Buy	71,600 +53,300	+291%	+$688K	0.01%	1059
2017 Q1	$19K	Buy	+18,300	New	+$132K	﹤0.01%	3384
2016 Q3	–	Sell	-6,600	Closed	-$1K	–	7162
2016 Q2	$1K	Buy	6,600 +2,500	+61%	+$31.3K	﹤0.01%	6172
2016 Q1	$3K	Buy	+4,100	New	+$58.8K	﹤0.01%	5304

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cutler Group's NVCR Position: Q1 2024 in Review

Cutler Group opened a new position in NovoCure (NVCR) in Q1 2024: 869 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #1188 among its holdings. This is a return to the name: Cutler Group previously reported a position in NVCR as recently as Q3 2023.

Cutler Group first reported a position in NVCR in Q4 2015 and has held it in 18 quarters since. The position peaked at $732K in Q4 2021. 237 funds tracked by Wall St. Rank hold NVCR as of Q1 2024.

Cutler Group held 869 shares of NovoCure worth $13K as of Q1 2024.
NovoCure was a new Cutler Group position in Q1 2024.
NovoCure made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1188 holding.
Cutler Group first reported a position in NovoCure in Q4 2015 and has held it in 18 quarters since.
Cutler Group's NovoCure position peaked at $732K in Q4 2021.
237 funds tracked by Wall St. Rank held NovoCure as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.